DOCSLIB.ORG

Manual of Psychedelic Support a Practical Guide to Establishing and Facilitating Care Services at Music Festivals and Other Events

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Manual of Psychedelic Support a Practical Guide to Establishing and Facilitating Care Services at Music Festivals and Other Events The Manual of Psychedelic Support A Practical Guide to Establishing and Facilitating Care Services at Music Festivals and Other Events Second Edition Multidisciplinary Association for Psychedelic Studies (MAPS) The Manual of Psychedelic Support GWYLLM LLWYDD • The Chemist (dedicated to Sasha Shulgin), 2013 • multimedia, digital collage http://www.gwyllm-art.com The Manual of Psychedelic Support Second Edition Multidisciplinary Association for Psychedelic Studies (MAPS) Copies of this Manual may be downloaded freely from http://www.psychsitter.com Sales of this book will help fund psychedelic harm reduction. The Manual of Psychedelic Support Second Edition (2017) Multidisciplinary Association for Psychedelic Studies (MAPS) Printed in China by Asia Pacific Offset ISBN 978-0-9982765-1-9 LICENSING & COPYRIGHT This work, excluding all art and photos, is licensed under a Creative Commons Attribution—Non-Commercial 4.0 Inter- national licence. You are free to Share (copy/redistribute in any medium) and Adapt (remix, transform, build upon) the text of this work, as long as you attribute its original source to The Manual of Psychedelic Support and provide a link to the CC BY-NC 4.0 licence https://creativecommons.org/licenses/by-nc/4.0/. Additionally, no part of this work may be used directly for commercial purposes. Art and photos in this work are copyright by their respective artists and photographers. EDITORS ANNIE OAK Founder of the Women’s Visionary Congress and the Full Circle Tea House JON HANNA Co-founder of Mind States KAYA SVEA NIELSEN Psychologist, Vision Board Coach, Nikken Consultant, and Mama of fine organic children TWILIGHT ZEVIC MISHOR, PhD FOREWORDS FIRE & EARTH EROWID Co-founders of Erowid Center, Erowid.org, and EcstasyData.org DIOGO RUIVO Founder of Good Mood Productions and the Boom Festival RICK DOBLIN, PhD Founder & Executive Director of the Multidisciplinary Association for Psychedelic Studies (MAPS) ALICIA DANFORTH, PhD Clinical Psychedelics Researcher SAM CUTLER Former Tour Manager for the Rolling Stones and the Grateful Dead AUTHORS ALEXANDRE QUARANTA, PhD Writer, Tantric Yoga Teacher, and Lucid Dreaming Trainer ALICIA DANFORTH, PhD Clinical Psychedelics Researcher ANNIE OAK Founder of the Women’s Visionary Congress and the Full Circle Tea House BEN ATKINSON Critical Incident Debriefer/Crisis Care Worker BEN HOLDEN Board Member & Lead Volunteer for KosmicAid, and Harm Reduction Outreach Worker (Leeds, United Kingdom) BERRY CHRISTOPHER J. WARD CONSTANCE RODRIGUES Clinical Psychologist, Somatic-Psychotherapist, Pilot for KosmiCare Boom Festival (2010), Teacher & Co-founder of the Portuguese Center of Jungian Studies CONSTANTINOS EFSTRATIOU DANIEL LEUENBERGER Trance-lator, DJ Almacalma, and Daddy ELISSA HARWOOD Researcher EMMA METCALF GASTONE ZANETTE (Gas), MD Anaesthesiologist GRACE LIEW IGOR DOMSAC Psychonaut, Artist, Father, and Founder of Alter Consciens ISLA CAMILLE DUPORGE JACK LIEBERMAN JACOB POTKONYAK JOAN OBIOLS-LLANDRICH, MD, PhD Psychiatrist and Anthropologist JOÃO GONÇALVES JON HANNA Co-founder of Mind States JONAS DI GREGORIO KAI SCHULZE KARIN SILENZI DE STAGNI Coordinator of KosmicAid KAYA KIM PENDERS LEVENTE MÓRÓ Coordinator for DÁT2 Psy Help LINNAE PONTÉ Former Director of Harm Reduction (Zendo Project) for MAPS MARC B. AIXALÀ MARIA CARMO CARVALHO Lecturer at the Faculty of Education, Catholic University of Portugal at Porto, and Pilot & Research Coordinator for KosmiCare Boom Festival (2010) MARIANA PINTO DE SOUSA Researcher for KosmiCare Boom Festival MIMI PELEG Director of Large Scale Cannabis Training at MECHKAR Israel, and Clinical Research Associate for the MAPS MINTY DE LA PLAYA NATACHA RIBEIRO RICK DOBLIN, PhD Founder & Executive Director of MAPS SNU VOOGELBREINDER Ethnobotanical Author and Psychonaut SVEA NIELSEN Psychologist, Vision Board Coach, Nikken Consultant, and Mama of fine organic children TIMOTHY BAKAS TOM SHUTTE Psychotherapist TRACY DUNNE Secretary & Care Service Leader for KosmicAid TWILIGHT XAVIER URQUIAGA A. VINCE CAKIC ZEVIC MISHOR, PhD ARTISTS ALEX GREY http://www.alexgrey.com ALLYSON GREY http://www.allysongrey.com FRED TOMASELLI http://www.jamescohan.com/artists/fred-tomaselli GWYLLM LLWYDD http://www.gwyllm-art.com JON HANNA http://www.mindstates.org LUKE BROWN http://www.spectraleyes.com LUKE GRAY http://www.lukegray.net MARK HENSON http://www.markhensonart.com MARTINA HOFFMANN http://www.martinahoffmann.com NAOTO HATTORI http://www.naotohattori.com ROBERT VENOSA http://www.venosa.com SHANNON THERON http://plus.google.com/+ShannonTheron/posts SHANTIQ http://www.saatchiart.com/shantiq VIBRATA CHROMODORIS http://www.vibrata.com ZEVIC MISHOR, PhD PHOTOGRAPHERS DAVID ARNSON Founder of the Insect Surfers and the Raw Power Rangers EROWID http://www.erowid.org GREG MANNING JEN ZARIAT http://www.zariat.com JOHN COCKTOASTEN JON HANNA Co-founder of Mind States LEANDRO REINALDO Anaesthesiologist, Medical Doctor MADDIE RADNAN Co-founder of Yo! Mad Dreadlocks, BSc. (Hons) Student, and Psychonaut SUSANA SANTOS Social Worker VIBRATA CHROMODORIS http://www.vibrata.com ZEVIC MISHOR, PhD DESIGN TEAM BLAKE HANNA Proofreader • Educator and Cat Whisperer DAVE KING Web Design • Co-director of Breaking Convention JON HANNA Art & Photography Editor • Co-founder of Mind States LUKE GRAY Cover Artwork • http://www.lukegray.net MARK PLUMMER Book & Cover Design SARAH JORDAN Production CONTRIBUTORS ANA PAULA SILVA COSTA D.J. SIMMS DAVE KING Co-director of Breaking Convention GWYLLM LLWYDD http://www.gwyllm-art.com IKER PUENTE JOANNA TARNAVA AMES within this Manual are generally arranged Nalphabetically by first name. Specific authors for each chapter are listed under that chapter’s heading, with bold type indicating the chapter leads—those who were respon- sible for coordinating the writing of that chapter. DISCLAIMER This book is designed to present helpful information and motivation to our readers on the subjects addressed. It is pro- vided with the understanding that its editors and its authors are not offering any type of psychological, medical, legal, or any other kind of professional advice. The content of each chapter is the sole expression and opinion of its authors, and not necessarily that of the editors. This book is not meant to be used, nor should it be used, to diagnose nor treat any medical, psychological, and/or physiological condition. For diagnosis or treatment of any medical, psychological, or physiological problem, consult a licensed physician. The editors and authors are not respon- sible for any specific health needs that may require medical supervision and shall not be held liable for any damages or negative consequences from any treatment, action, applica- tion, or preparation undertaken by and/or provided to any person reading or following the information in this book. References are provided for informational purposes only and do not constitute endorsement of any websites or other sources. Readers should be aware that the URLs listed in this book and/or the contents of their web sites may change at any time. Every situation is different. The advice and strategies con- tained in this Manual may not be suitable for your situation. The editors and authors make no representations or warran- ties of any kind and specifically disclaim any implied warran- ties of merchantability or fitness of use for a particular pur- pose. Neither the editors nor the authors shall be held liable to any person or entity for any loss, or for physical, psycho- logical, emotional, financial, and/or commercial damages, including, but not limited to, special, incidental, consequential or other damages caused, or alleged to have been caused, directly or indirectly by the information contained herein. The authors and editors retain their own views and rights. Readers are responsible for their own choices and results. FEEDBACK This Manual is an ongoing work, and we appreciate any comments or suggestions regarding its content. Feedback may be given at http://www.psychsitter.com. Dedicated... with deep respect to Dr. Andrew Sewell, a courageous healer and researcher who helped develop the principles presented in this Manual and applied them with great compassion; with love to David K. Lord, a precious friend on the Path who chose to go his own way. Travel well, dear Dave; 1. Drs. Albert Hofmann and Andrew Sewell displaying the Polish edition of LSD—My Problem Child. and in gratitude to Photo by Jon Hanna, 2008. Alexander T. Shulgin, 2. David K. Lord. pioneering chemist Photographer unknown. and pharmacologist 3. Sasha Shulgin on the playa in Black Rock City, Nevada, who created at the Burning Man Festival. numerous valuable Photo by Greg Manning, 2007. psychedelic tools. 4. David Best’s Temple of Honor, Black Rock City, Nevada, at the Burning Man Festival. Photo by Jon Hanna, 2003. Contents Forewords...........................................................................................1 Introduction......................................................................................13 1. A History of Psychedelic Care Services.............................19 2. The Principles and Ethics of Psychedelic Support............37 3. Legal Considerations............................................................. 49 4. Planning and First Steps for a New Project......................59 5. Recruiting a Team...................................................................67 6. Supporting Roles....................................................................79 7. Building and Training a Team..............................................87
Load more

Recommended publications
  • Cactus Chronicle
    Volume 78 Issue 8 HolidayCACTUS Party CHRONICLE August 2013 Mission Statement: Plant of the Month The Los Angeles Cactus and Succulent Society (LACSS) cultivates the study and enjoyment Stenocactus Bursera, of cacti and succulent plants through educational programs and activities that promote the Commiphora hobby within a community of fellow enthusiasts and among the greater public. Refreshments Our next general meeting is Letters U-Z August 1 July New Members Pat Byrne Janice B. Lee Program Title: The Exotic Fauna and Flora of East Africa Lynn Ruger Anika Russell Lauren Stanton Presented by Steve Frieze Sonia Villarroel Editor Phyllis Frieze [email protected] Visit Us on the web http:// www.lacss.com Steve Frieze is a past president of the LACSS and has served the club in numerous other capac- ities during the past 25 years he has been a member. He is currently a partner of Desert Crea- tions, a plant store that sells unusual cacti and succulents. He has traveled to numerous loca- tions that house exotic plants, including Chile, Brazil, and Oaxaca Mexico which he just returned from. This presentation will concentrate on a trip to Tanzania he took three years ago and the wonderful succulent plants and animals that are endemic to this geographic location. You will have an opportunity to see specimen size plants such as Adenias and Commiphoras that over- whelm the senses. In addition, you will be exposed to fauna that you, in many cases, could reach out and touch if you had a touch of insanity. In one instance his tour stumbled across a fully grown lion sleeping the roadway no more than five feet from the vehicle that he was sitting in.
    [Show full text]
  • Protabase Record Display Datura Stramonium L
    Protabase Record display www.prota.org Datura stramonium L. Protologue Sp. pl. 1: 179 (1753). Family Solanaceae Chromosome number 2n = 24 Vernacular names Thorn apple, green thorn apple, Jimson weed, Jamestown weed, devil’s apple, devil’s trumpet, stramonium (En). Pomme épineuse, stramoine, datura, feuille du diable, herbe du diable (Fr). Figueira do inferno, pomo espinhoso, erva dos bruxos, palha verde, estramonio (Po). Muranha (Sw). Origin and geographic distribution Datura stramonium is native to the Americas and has been introduced in many tropical, subtropical and even temperate regions. It is a naturalized weed in many African countries, but is probably seriously under-reported. Uses Datura stramonium and Datura metel L. have largely similar medicinal uses throughout the world. The most widely known use of Datura stramonium and of other Datura species is for relieving asthma, cough, tuberculosis and bronchitis by smoking the dried leaves, roots or flowers. ‘Asthma cigarettes’ have been shown to be very effective in some cases, but in other cases they had little or no effect. Cigarettes made with the leaves are also used to treat Parkinson’s disease. A decoction or infusion of leaves is given as a sedative to mental and schizophrenic patients. The leaves are applied as a dressing to cure rheumatic pain, swellings, wounds, gout, burns, ingrown toe-nails, fungal infections, tumours and ulcers. Dried pulverized leaves are dusted on wounds or applied after mixing the powder with fat or Vaseline. In DR Congo pounded fresh root and fresh leaves are soaked in water and the liquid is given in enema as an abortifacient.
    [Show full text]
  • Nightshade”—A Hierarchical Classification Approach to T Identification of Hallucinogenic Solanaceae Spp
    Talanta 204 (2019) 739–746 Contents lists available at ScienceDirect Talanta journal homepage: www.elsevier.com/locate/talanta Call it a “nightshade”—A hierarchical classification approach to T identification of hallucinogenic Solanaceae spp. using DART-HRMS-derived chemical signatures ∗ Samira Beyramysoltan, Nana-Hawwa Abdul-Rahman, Rabi A. Musah Department of Chemistry, State University of New York at Albany, 1400 Washington Ave, Albany, NY, 12222, USA ARTICLE INFO ABSTRACT Keywords: Plants that produce atropine and scopolamine fall under several genera within the nightshade family. Both Hierarchical classification atropine and scopolamine are used clinically, but they are also important in a forensics context because they are Psychoactive plants abused recreationally for their psychoactive properties. The accurate species attribution of these plants, which Seed species identifiction are related taxonomically, and which all contain the same characteristic biomarkers, is a challenging problem in Metabolome profiling both forensics and horticulture, as the plants are not only mind-altering, but are also important in landscaping as Direct analysis in real time-mass spectrometry ornamentals. Ambient ionization mass spectrometry in combination with a hierarchical classification workflow Chemometrics is shown to enable species identification of these plants. The hierarchical classification simplifies the classifi- cation problem to primarily consider the subset of models that account for the hierarchy taxonomy, instead of having it be based on discrimination between species using a single flat classification model. Accordingly, the seeds of 24 nightshade plant species spanning 5 genera (i.e. Atropa, Brugmansia, Datura, Hyocyamus and Mandragora), were analyzed by direct analysis in real time-high resolution mass spectrometry (DART-HRMS) with minimal sample preparation required.
    [Show full text]
  • Substance Abuse and Dependence
    9 Substance Abuse and Dependence CHAPTER CHAPTER OUTLINE CLASSIFICATION OF SUBSTANCE-RELATED THEORETICAL PERSPECTIVES 310–316 Residential Approaches DISORDERS 291–296 Biological Perspectives Psychodynamic Approaches Substance Abuse and Dependence Learning Perspectives Behavioral Approaches Addiction and Other Forms of Compulsive Cognitive Perspectives Relapse-Prevention Training Behavior Psychodynamic Perspectives SUMMING UP 325–326 Racial and Ethnic Differences in Substance Sociocultural Perspectives Use Disorders TREATMENT OF SUBSTANCE ABUSE Pathways to Drug Dependence AND DEPENDENCE 316–325 DRUGS OF ABUSE 296–310 Biological Approaches Depressants Culturally Sensitive Treatment Stimulants of Alcoholism Hallucinogens Nonprofessional Support Groups TRUTH or FICTION T❑ F❑ Heroin accounts for more deaths “Nothing and Nobody Comes Before than any other drug. (p. 291) T❑ F❑ You cannot be psychologically My Coke” dependent on a drug without also being She had just caught me with cocaine again after I had managed to convince her that physically dependent on it. (p. 295) I hadn’t used in over a month. Of course I had been tooting (snorting) almost every T❑ F❑ More teenagers and young adults die day, but I had managed to cover my tracks a little better than usual. So she said to from alcohol-related motor vehicle accidents me that I was going to have to make a choice—either cocaine or her. Before she than from any other cause. (p. 297) finished the sentence, I knew what was coming, so I told her to think carefully about what she was going to say. It was clear to me that there wasn’t a choice. I love my T❑ F❑ It is safe to let someone who has wife, but I’m not going to choose anything over cocaine.
    [Show full text]
  • PDF Download
    CURRENT THERAPEUTIC RESEARCH VOL. 56, NO. 5, MAY 1995 EFFECTS OF CEREBRAL METABOLIC ENHANCERS ON BRAIN FUNCTION IN RODENTS KOICHIRO TAKAHASHI,l MINORU YAMAMOTO,’ MASANORI SUZUKI,’ YUKIKO OZAWA,’ TAKASHI YAMAGUCHI,l HIROFUMI ANDOH, AND KOUICHI ISHIKAWA2 ‘Department of Pharmacology, Clinical Pharmacology Research Laboratory, Yamunouchi Pharmaceutical Co. Ltd., and ‘Department of Pharmacology, School of Medicine, Nihon University, Tokyo, Japan AFWI’RACT The effects of cerebral metabolic enhancers (indeloxazine, bi- femelane, idebenone, and nicergoline) on reserpine-induced hypother- mia, the immobility period in forced swimming tests, and passive avoidance learning behavior were compared with the effects of ami- triptyline in rodents. Indeloxazine, bifemelane, and amitriptyline antagonized hypothermia in mice given reserpine. Indeloxaxine and amitriptyline decreased the immobility period in mice in the forced swimming test in a dose-dependent manner. The latency of step- through in the passive avoidance test in rats was prolonged by ad- ministration of indeloxazine but shortened by administration of amitriptyline. Neither idebenone nor nicergoline displayed any phar- macologic action in these tests. The results suggest that indeloxaxine possesses an antidepressant activity similar to that of amitriptyline but differs from amitriptyline in its anticholinergic properties and its ability to ameliorate impaired brain function such as that of learning behavior. In addition, indeloxazine exhibited broader effects on brain functions than either bifemelane, idebenone, or nicergoline. INTRODUCTION Cerebral metabolic enhancers (drugs that enhance energy metabolism) including brain glucose and ATP levels such as indeloxazine,1*2 bi- femelane, 3*4idebenone?6 and nicergoline,7>8 are currently used for the treatment of patients with various psychiatric symptoms. These symptoms include reduced spontaneity and emotional disturbance in patients with cerebral vascular disease.
    [Show full text]
  • )&F1y3x PHARMACEUTICAL APPENDIX to THE
    )&f1y3X PHARMACEUTICAL APPENDIX TO THE HARMONIZED TARIFF SCHEDULE )&f1y3X PHARMACEUTICAL APPENDIX TO THE TARIFF SCHEDULE 3 Table 1. This table enumerates products described by International Non-proprietary Names (INN) which shall be entered free of duty under general note 13 to the tariff schedule. The Chemical Abstracts Service (CAS) registry numbers also set forth in this table are included to assist in the identification of the products concerned. For purposes of the tariff schedule, any references to a product enumerated in this table includes such product by whatever name known. Product CAS No. Product CAS No. ABAMECTIN 65195-55-3 ACTODIGIN 36983-69-4 ABANOQUIL 90402-40-7 ADAFENOXATE 82168-26-1 ABCIXIMAB 143653-53-6 ADAMEXINE 54785-02-3 ABECARNIL 111841-85-1 ADAPALENE 106685-40-9 ABITESARTAN 137882-98-5 ADAPROLOL 101479-70-3 ABLUKAST 96566-25-5 ADATANSERIN 127266-56-2 ABUNIDAZOLE 91017-58-2 ADEFOVIR 106941-25-7 ACADESINE 2627-69-2 ADELMIDROL 1675-66-7 ACAMPROSATE 77337-76-9 ADEMETIONINE 17176-17-9 ACAPRAZINE 55485-20-6 ADENOSINE PHOSPHATE 61-19-8 ACARBOSE 56180-94-0 ADIBENDAN 100510-33-6 ACEBROCHOL 514-50-1 ADICILLIN 525-94-0 ACEBURIC ACID 26976-72-7 ADIMOLOL 78459-19-5 ACEBUTOLOL 37517-30-9 ADINAZOLAM 37115-32-5 ACECAINIDE 32795-44-1 ADIPHENINE 64-95-9 ACECARBROMAL 77-66-7 ADIPIODONE 606-17-7 ACECLIDINE 827-61-2 ADITEREN 56066-19-4 ACECLOFENAC 89796-99-6 ADITOPRIM 56066-63-8 ACEDAPSONE 77-46-3 ADOSOPINE 88124-26-9 ACEDIASULFONE SODIUM 127-60-6 ADOZELESIN 110314-48-2 ACEDOBEN 556-08-1 ADRAFINIL 63547-13-7 ACEFLURANOL 80595-73-9 ADRENALONE
    [Show full text]
  • Adverse Reactions to Hallucinogenic Drugs. 1Rnstttutton National Test
    DOCUMENT RESUME ED 034 696 SE 007 743 AUTROP Meyer, Roger E. , Fd. TITLE Adverse Reactions to Hallucinogenic Drugs. 1rNSTTTUTTON National Test. of Mental Health (DHEW), Bethesda, Md. PUB DATP Sep 67 NOTE 118p.; Conference held at the National Institute of Mental Health, Chevy Chase, Maryland, September 29, 1967 AVATLABLE FROM Superintendent of Documents, Government Printing Office, Washington, D. C. 20402 ($1.25). FDPS PRICE FDPS Price MFc0.50 HC Not Available from EDRS. DESCPTPTOPS Conference Reports, *Drug Abuse, Health Education, *Lysergic Acid Diethylamide, *Medical Research, *Mental Health IDENTIFIEPS Hallucinogenic Drugs ABSTPACT This reports a conference of psychologists, psychiatrists, geneticists and others concerned with the biological and psychological effects of lysergic acid diethylamide and other hallucinogenic drugs. Clinical data are presented on adverse drug reactions. The difficulty of determining the causes of adverse reactions is discussed, as are different methods of therapy. Data are also presented on the psychological and physiolcgical effects of L.S.D. given as a treatment under controlled medical conditions. Possible genetic effects of L.S.D. and other drugs are discussed on the basis of data from laboratory animals and humans. Also discussed are needs for futher research. The necessity to aviod scare techniques in disseminating information about drugs is emphasized. An aprentlix includes seven background papers reprinted from professional journals, and a bibliography of current articles on the possible genetic effects of drugs. (EB) National Clearinghouse for Mental Health Information VA-w. Alb alb !bAm I.S. MOMS Of NAM MON tMAN IONE Of NMI 105 NUNN NU IN WINES UAWAS RCM NIN 01 NUN N ONMININI 01011110 0.
    [Show full text]
  • Psychoactive Substances and Transpersonal States
    TRANSPERSONAL PSYCHOLOGY RESEARCH REVIEW: PSYCHOACTIVE SUBSTANCES AND TRANSPERSONAL STATES David Lukoff San Francisco, California Robert Zanger Los Angeles, California Francis Lu San Francisco, California This "Research Review" covers recent trends in researching psychoactive substances and trans personal states of conscious­ ness during the past ten years. In keeping with the stated goals of this section of the Journal to promote research in transpersonal psychology, the focus is on the methods and trends designs which are being employed in investigations rather than during the findings on this topic. However, some recently published the books and monographs provide good summaries of the recent last findings relevant to understanding psychoactive substances ten (Cohen & Krippner, 1985b; Dobkin de Rios, 1984;Dobkin de years Rios & Winkelman, 1989b; Ratsch, 1990; Reidlinger, 1990). Because researching psychoactive substances is most broadly a cross-disciplinary venture, only a small portion of the research reviewed below was conducted by persons who consider The authors wish to acknowledge the assistance of Bruce Flath, head librarian at the California Institute of Integral Studies, San Francisco in conducting the computer bibliographic searches used in preparation of this article. The authors also wish to thank Marlene Dobkin de Rios, Stanley Krippner, Christel Lukoff, Dennis McKenna, Terence McKenna, Ralph Metzner, Donald Rothberg and Ilene Serlin for their valuable comments on earlier drafts of this article. Copyright © 1990 Transpersonal Institute The Journal of Transpersonal Psychology. 1990, Vol. 22, No.2 107 themselves transpersonal psychologists. As Vaughan (1984) has noted, "The transpersonal perspective is a meta-perspec­ tive, an attempt to learn from all different disciplines . emerging from the needed integration of ancient wisdom and modern science.
    [Show full text]
  • Psilocybin Mushrooms Fact Sheet
    Psilocybin Mushrooms Fact Sheet January 2017 What are psilocybin, or “magic,” mushrooms? For the next two decades thousands of doses of psilocybin were administered in clinical experiments. Psilocybin is the main ingredient found in several types Psychiatrists, scientists and mental health of psychoactive mushrooms, making it perhaps the professionals considered psychedelics like psilocybin i best-known naturally-occurring psychedelic drug. to be promising treatments as an aid to therapy for a Although psilocybin is considered active at doses broad range of psychiatric diagnoses, including around 3-4 mg, a common dose used in clinical alcoholism, schizophrenia, autism spectrum disorders, ii,iii,iv research settings ranges from 14-30 mg. Its obsessive-compulsive disorder, and depression.xiii effects on the brain are attributed to its active Many more people were also introduced to psilocybin metabolite, psilocin. Psilocybin is most commonly mushrooms and other psychedelics as part of various found in wild or homegrown mushrooms and sold religious or spiritual practices, for mental and either fresh or dried. The most popular species of emotional exploration, or to enhance wellness and psilocybin mushrooms is Psilocybe cubensis, which is creativity.xiv usually taken orally either by eating dried caps and stems or steeped in hot water and drunk as a tea, with Despite this long history and ongoing research into its v a common dose around 1-2.5 grams. therapeutic and medical benefits,xv since 1970 psilocybin and psilocin have been listed in Schedule I of the Controlled Substances Act, the most heavily Scientists and mental health professionals criminalized category for drugs considered to have a consider psychedelics like psilocybin to be “high potential for abuse” and no currently accepted promising treatments as an aid to therapy for a medical use – though when it comes to psilocybin broad range of psychiatric diagnoses.
    [Show full text]
  • Neuroreceptor Activation by Vibration-Assisted Tunneling
    OPEN Neuroreceptor Activation by SUBJECT AREAS: Vibration-Assisted Tunneling BIOPHYSICAL CHEMISTRY Ross D. Hoehn1, David Nichols2, Hartmut Neven3 & Sabre Kais4,5,6 MECHANISM OF ACTION 1Department of Chemistry, Purdue University, West Lafayette, IN 47907, USA, 2Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, IN 47907, USA,3 Google, Venice, CA 90291, USA,4 Department of Received 5 20 October 2014 Chemistry, Purdue University, West Lafayette, IN 47907, USA, Departments of Physics, Purdue University, West Lafayette, IN 47907, USA,6 Qatar Environment and Energy Research Institute, Qatar Foundation, Doha, Qatar. Accepted 20 March 2015 G protein-coupled receptors (GPCRs) constitute a large family of receptor proteins that sense molecular Published signals on the exterior of a cell and activate signal transduction pathways within the cell. Modeling how an 24 April 2015 agonist activates such a receptor is fundamental for an understanding of a wide variety of physiological processes and it is of tremendous value for pharmacology and drug design. Inelastic electron tunneling spectroscopy (IETS) has been proposed as a model for the mechanism by which olfactory GPCRs are activated by a bound agonist. We apply this hyothesis to GPCRs within the mammalian nervous system Correspondence and using quantum chemical modeling. We found that non-endogenous agonists of the serotonin receptor share requests for materials a particular IET spectral aspect both amongst each other and with the serotonin molecule: a peak whose should be addressed to intensity scales with the known agonist potencies. We propose an experiential validation of this model by S.K. (kais@purdue. utilizing lysergic acid dimethylamide (DAM-57), an ergot derivative, and its deuterated isotopologues; we also provide theoretical predictions for comparison to experiment.
    [Show full text]
  • Near the Himalayas, from Kashmir to Sikkim, at Altitudes the Catholic Inquisition, and the Traditional Use of These of up to 2700 Meters
    Year of edition: 2018 Authors of the text: Marc Aixalà & José Carlos Bouso Edition: Alex Verdaguer | Genís Oña | Kiko Castellanos Illustrations: Alba Teixidor EU Project: New Approaches in Harm Reduction Policies and Practices (NAHRPP) Special thanks to collaborators Alejandro Ponce (in Peyote report) and Eduardo Carchedi (in Kambó report). TECHNICAL REPORT ON PSYCHOACTIVE ETHNOBOTANICALS Volumes I - II - III ICEERS International Center for Ethnobotanical Education Research and Service INDEX SALVIA DIVINORUM 7 AMANITA MUSCARIA 13 DATURA STRAMONIUM 19 KRATOM 23 PEYOTE 29 BUFO ALVARIUS 37 PSILOCYBIN MUSHROOMS 43 IPOMOEA VIOLACEA 51 AYAHUASCA 57 IBOGA 67 KAMBÓ 73 SAN PEDRO 79 6 SALVIA DIVINORUM SALVIA DIVINORUM The effects of the Hierba Pastora have been used by Mazatec Indians since ancient times to treat diseases and for divinatory purposes. The psychoactive compound Salvia divinorum contains, Salvinorin A, is the most potent naturally occurring psychoactive substance known. BASIC INFO Ska Pastora has been used in divination and healing Salvia divinorum is a perennial plant native to the Maza- rituals, similar to psilocybin mushrooms. Maria Sabina tec areas of the Sierra Madre Oriental Mountains of Mexi- told Wasson and Hofmann (the discoverers of its Mazatec co. Its habitat is tropical forests, where it grows between usage) that Salvia divinorum was used in times when the- 300 and 800 meters above sea level. It belongs to the re was a shortage of mushrooms. Some sources that have Lamiaceae family, and is mainly reproduced by cuttings done later feldwork point out that the use of S. divinorum since it rarely produces seeds. may be more widespread than originally believed, even in times when mushrooms were abundant.
    [Show full text]
  • Microgram Journal, Vol 2, Number 1
    Washington, D. C. Office of Science and Education Vol.II,No.1 Division of Laboratory Operations January 1969 INDEXISSUE CORRECTION 11 "Structure Elucidation of 'LBJ' , by Sander W. Bellman, John W. Turczan, James Heagy and Ted M. Hopes, Micro­ Gram .!., 3, 6-13 (Dec. 1968) Page 7, third and fourth sentences under Discussion: Change to read: "The melting point of the acid moiety found in step (g) was 148-150°c., compared to the litera­ ture, v~lue of 151°c for the melting point of benzilic acid (2); thus the benzilic acid melting point gives support to the proposed structure for 'LBJ'. Spectral evidence also supports the proposed structure". MICRO-GRAMREVISION Please re-number the pages of your copies of Micro-Gram, Volume I. Re-number pages bearing printing only. Vol­ ume I will then be numbered from page 1, the front page of issue No. 1, through page 189 the last page of issue No. 12. To help with this task, pages contained within each issue are as follows: Issue Number Page Through 1 1 8 2 9 29 3 30 32 4 33 66 5 67 79 6 80 97 7 98 120 8 121 128 9 129 136 10 137 157 11 158 170 12 171 189 CAUTION: Use of this publication should be restricted to forensic analysts or others having a legitimate need for this material. From the Archive Library of Erowid Center http://erowid.org/library/periodicals/microgram -2- CANNABIS ,·,-...__/' Attached is a copy of 11A Short Rapid Method for the Identification of Cannabis." The method was developed by Mro H.D.
    [Show full text]